General discussion 293 van Dijk, D., Dekker, M. J. H. J., Conemans, E. B., Wiepjes, C. M., de Goeij, E. G. M., Overbeek, K. A., Fisher, A. D., den Heijer, M., & T’Sjoen, G. (2019). Explorative Prospective Evaluation of Short-Term Subjective Effects of Hormonal Treatment in Trans People—Results from the European Network for the Investigation of Gender Incongruence. The Journal of Sexual Medicine, 16(8), 1297-1309. https://doi.org/10.1016/j.jsxm.2019.05.009 Vandegrift, B. J., You, C., Satta, R., Brodie, M. S., & Lasek, A. W. (2017). Estradiol increases the sensitivity of ventral tegmental area dopamine neurons to dopamine and ethanol. PLOS ONE, 12(11), e0187698. https://doi.org/10.1371/journal.pone.0187698 Verbeek, M. J. A., Hommes, M. A., Stutterheim, S. E., van Lankveld, J. J. D. M., & Bos, A. E. R. (2020). Experiences with stigmatization among transgender individuals after transition: A qualitative study in the Netherlands. International Journal of Transgender Health, 21(2), 220233. https://doi.org/10.1080/26895269.2020.1750529 Wassersug, R., Gray, R. E., Barbara, A., Trosztmer, C., Raj, R., & Sinding, C. (2007). Experiences of Transwomen with Hormone Therapy. Sexualities, 10(1), 101-122. https://doi.org/10.1177/ 1363460707072957 White, J., Tannenbaum, C., Klinge, I., Schiebinger, L., & Clayton, J. (2021). The Integration of Sex and Gender Considerations Into Biomedical Research: Lessons From International Funding Agencies. The Journal of Clinical Endocrinology & Metabolism, 106(10), 3034-3048. https://doi.org/10.1210/clinem/dgab434 Zucker, I., & Prendergast, B. J. (2020). Sex differences in pharmacokinetics predict adverse drug reactions in women. Biology of Sex Differences, 11(1), 32. https://doi.org/10.1186/s13293020-00308-5
RkJQdWJsaXNoZXIy MTk4NDMw